Timelines and outcomes vary by individual, and not all patients are candidates.
Packaging is designed to maintain compound stability during transport and storage
Monitoring and follow-up: Routine blood monitoring of B12 levels after treatment initiation is generally unnecessary, as levels will be artificially elevated
Cohen RD, Castellani LW, Qiao JH, Van Lenten BJ, Lusis AJ, Reue K
Nevertheless, grey-market versions of uncertain composition are readily accessible online and "legitimised" through social media marketing
Jorge Moreno, an obesity specialist at Yale Medicine, is already getting messages from his patients asking about the Bridge program, including some who had been denied coverage in the past